After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations.
This website will be accessible until September 2025, with all the information being up to date as of July 2024.
If you are a supplier, or another partner you can contact our legacy email address as aidsmap@outlook.com with any queries.
We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health or happiness. Together we have made a difference.
Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).
Pink News
The Lancet
The Body
AIDS Chicago
CATIE
Group Health Research Institute
CDC press release
Positively UK
Yale Daily News
Black AIDS Institute
AIDSMeds
Ethan The Blog
BETA
Science Speaks
PATH
Star Observer
Speaking Up! (blog)
Daily Mail
GayNZ